167 related articles for article (PubMed ID: 38716503)
1. Prognostic Significance of Excision Repair Cross-Complementation Group 1 on Circulating Tumor Cells for Nasopharyngeal Carcinoma.
Liu T; Li Y; Song J; Li B; Wang R; Huang T; Qin Y
Cancer Control; 2024; 31():10732748241251562. PubMed ID: 38716503
[TBL] [Abstract][Full Text] [Related]
2. Is excision repair cross-complementation Group1 expression a biological marker in nasopharynx carcinoma?
Aksoy A; Elkiran ET; Harputluoglu H; Dagli AF; Isikdogan A; Urakci Z
J Cancer Res Ther; 2019; 15(3):550-555. PubMed ID: 31169219
[TBL] [Abstract][Full Text] [Related]
3. High/positive expression of ERCC1 predicts poor treatment response and survival prognosis in nasopharyngeal carcinoma: A systematic meta-analysis from 21 studies.
Yang L; Wei W; Zhou L; Wang J; Hu G
Medicine (Baltimore); 2019 May; 98(21):e15641. PubMed ID: 31124943
[TBL] [Abstract][Full Text] [Related]
4. Circulating tumor cells: a valuable indicator for locally advanced nasopharyngeal carcinoma.
Liu T; Liu J; Wang G; Chen C; He L; Wang R; Ouyang C
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38733533
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of excision repair cross- complementation group 1 expression in locoregionally advanced nasopharyngeal carcinoma receiving cisplatin-based concurrent chemoradiotherapy.
Wang D; Zhou J; Zheng J; Zhang J; Chen Y; Li W; Wang R
Cancer Biomark; 2018; 21(4):875-881. PubMed ID: 29439312
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal marker and LGR5 expression levels in circulating tumor cells correlate with colorectal cancer prognosis.
Wang W; Wan L; Wu S; Yang J; Zhou Y; Liu F; Wu Z; Cheng Y
Cell Oncol (Dordr); 2018 Oct; 41(5):495-504. PubMed ID: 29949050
[TBL] [Abstract][Full Text] [Related]
7. Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients.
You R; Liu YP; Lin M; Huang PY; Tang LQ; Zhang YN; Pan Y; Liu WL; Guo WB; Zou X; Zhao KM; Kang T; Liu LZ; Lin AH; Hong MH; Mai HQ; Zeng MS; Chen MY
Int J Cancer; 2019 Nov; 145(10):2873-2883. PubMed ID: 31044420
[TBL] [Abstract][Full Text] [Related]
8. Expression of excision repair cross-complementation group 1 in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy.
Shen C; Chen L; Fu J; Lin H
J Cancer Res Ther; 2016 Oct; 12(Supplement):72-75. PubMed ID: 27721259
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells: a valuable marker of poor prognosis for advanced nasopharyngeal carcinoma.
Ou G; Xing S; Li J; Zhang L; Chen S
Mol Med; 2019 Nov; 25(1):50. PubMed ID: 31729954
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
Lu G; Lu Z; Li C; Huang X; Luo Q
Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
[TBL] [Abstract][Full Text] [Related]
11. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer.
Chebouti I; Kuhlmann JD; Buderath P; Weber S; Wimberger P; Bokeloh Y; Hauch S; Kimmig R; Kasimir-Bauer S
Oncotarget; 2017 Apr; 8(15):24303-24313. PubMed ID: 28388557
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of circulating tumor cells and their expression of cyclooxygenase-2 in patients with nasopharyngeal carcinoma.
Xie XQ; Luo Y; Ma XL; Li SS; Liu L; Zhang H; Li P; Wang F
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6951-6961. PubMed ID: 31486495
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
[TBL] [Abstract][Full Text] [Related]
14. Expression of ERCC1 predicts clinical outcome in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy.
Huang PY; Li Y; Mai HQ; Luo RZ; Cai YC; Zhang L
Oral Oncol; 2012 Oct; 48(10):964-968. PubMed ID: 22571922
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition classification of circulating tumor cells predicts clinical outcomes in progressive nasopharyngeal carcinoma.
Wei J; Deng W; Weng J; Li M; Lan G; Li X; Ye L; Wang Y; Liu F; Ou H; Wei Y; Huang W; Xie S; Dong G; Qu S
Front Oncol; 2022; 12():988458. PubMed ID: 36212389
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of circulating tumor cell measurement in the peripheral blood of patients with nasopharyngeal carcinoma.
Gao T; Mao J; Huang J; Luo F; Lin L; Lian Y; Bin S; Zhao L; Li S
Clinics (Sao Paulo); 2023; 78():100179. PubMed ID: 36963168
[TBL] [Abstract][Full Text] [Related]
17. High Expression of BCAR1 by Circulating Tumor Cells and Tumor Tissues Is Predictive of a Poor Prognosis of Early-Stage Lung Adenocarcinoma Potentially Due to Regulation of Epithelial-Mesenchymal Transition.
Jiang S; Mao C; Jiang B; Tan Q; Deng B
Technol Cancer Res Treat; 2020; 19():1533033820983086. PubMed ID: 33334252
[TBL] [Abstract][Full Text] [Related]
18. Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance.
Fu X; Shen C; Wang H; Chen F; Li G; Wen Z
BMC Cancer; 2017 Jul; 17(1):479. PubMed ID: 28693532
[TBL] [Abstract][Full Text] [Related]
19. Low expression of excision repair cross-complementation group-1 protein predicts better outcome in patients with locally advanced nasopharyngeal cancer treated with concurrent chemoradiotherapy.
Zhang Z; Jiang C; Hu L
Tumori; 2014; 100(3):328-32. PubMed ID: 25076246
[TBL] [Abstract][Full Text] [Related]
20. High SRC-1 and Twist1 expression predicts poor prognosis and promotes migration and invasion by inducing epithelial-mesenchymal transition in human nasopharyngeal carcinoma.
Zhou J; Zhang J; Xu M; Ke Z; Zhang W; Mai J
PLoS One; 2019; 14(4):e0215299. PubMed ID: 30973923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]